Subscribe To
Dbv technologies shares jump on positive data from peanut allergy trial in toddlers
DBV Technologies SA's (NASDAQ: DBVT) pivotal Phase 3 EPITOPE trial of Viaskin peanut 250 µg for ...
June 8, 2022, 7:24 am
J.m. smucker says peanut butter recall to weigh on fiscal 2023 results
JM Smucker Co. shares SJM, +0.40% slid 3.5% in premarket trade Tuesday, after the parent to brands inlcuidng Folgers, Jif and Milk-Bone posted better-...
June 7, 2022, 7:08 am
More products with jif peanut butter recalled over salmonella concerns
Several companies have recalled products that contain Jif peanut butter amid an outbreak of salmonel...
May 26, 2022, 2:25 pm
Smucker (sjm) stock dips on jif peanut butter recall
J M Smucker (SJM) stock is falling on Monday after the food company announced a recall of Jif peanut bu...
May 23, 2022, 12:05 pm
J.m. smucker is recalling some jif peanut butter products due to salmonella
J.M. Smucker is recalling certain types of Jif peanut butter in the US because of a potential salmonell...
May 22, 2022, 9:10 am
Hormel is recalling 161,692 pounds of skippy peanut butter
Hormel Foods is recalling thousands of pounds of Skippy peanut butter because of stainless steel fragme...
March 31, 2022, 11:27 pm
2 dirt cheap biotechs to buy if you're a contrarian
Today's losers are selling for peanuts, and they just might become tomorrow's winners....
March 5, 2022, 11:07 am
2 dirt cheap biotechs to buy if you're a contrarian
Today's losers are selling for peanuts, and they just might become tomorrow's winners....
March 5, 2022, 11:07 am
Allergy therapeutics primed for a pivotal year
Allergy Therapeutics PLC (AIM:AGY) said it was primed for a pivotal year as it prepared to get two key clinical trials underway. A ground-breaking pha...
March 3, 2022, 3:58 am
Allergy therapeutics primed for a pivotal year
Allergy Therapeutics PLC (AIM:AGY) said it was primed for a pivotal year as it prepared to get two key clinical trials underway. A ground-breaking pha...
March 3, 2022, 3:58 am
Allergy therapeutics primed for a pivotal year
Allergy Therapeutics PLC (AIM:AGY) said it was primed for a pivotal year as it prepared to get two key clinical trials underway. A ground-breaking pha...
March 3, 2022, 3:58 am
Allergy therapeutics shares up 9% after it gets the fda green light to begin phase i peanut allergy trial
Shares in Allergy Therapeutics PLC (AIM:AGY) rose 9% in early trade after the group said the US regulator had given the green light for trials to begi...
January 26, 2022, 3:21 am
Allergy therapeutics shares up 9% after it gets the fda green light to begin phase i peanut allergy trial
Shares in Allergy Therapeutics PLC (AIM:AGY) rose 9% in early trade after the group said the US regulator had given the green light for trials to begi...
January 26, 2022, 3:21 am
Allergy therapeutics shares up 9% after it gets the fda green light to begin phase i peanut allergy trial
Shares in Allergy Therapeutics PLC (AIM:AGY) rose 9% in early trade after the group said the US regulator had given the green light for trials to begi...
January 26, 2022, 3:21 am